These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11420080)

  • 1. Low-level lead exposure modulates effects of quinpirole and eticlopride on response rates in a fixed-interval schedule.
    Areola OO; Jadhav AL
    Pharmacol Biochem Behav; 2001; 69(1-2):151-6. PubMed ID: 11420080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead-induced decrements in waiting behavior: involvement of D2-like dopamine receptors.
    Brockel BJ; Cory-Slechta DA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):423-34. PubMed ID: 10418784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.
    Izzo E; Orsini C; Koob GF; Pulvirenti L
    Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dopamine agonists on fixed interval schedule-controlled behavior are selectively altered by low-level lead exposure.
    Cory-Slechta DA; Pokora MJ; Preston RA
    Neurotoxicol Teratol; 1996; 18(5):565-75. PubMed ID: 8888021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Cook CD; Newman JL; Winfree JC; Beardsley PM
    Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats.
    Frederick DL; Allen JD
    Pharmacol Biochem Behav; 1996 Apr; 53(4):759-64. PubMed ID: 8801575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
    Cory-Slechta DA; O'Mara DJ; Brockel BJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):794-805. PubMed ID: 9694936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior.
    Cory-Slechta DA; Brockel BJ; O'Mara DJ
    Neurotoxicology; 2002 Sep; 23(3):313-27. PubMed ID: 12387360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinpirole on timing behaviour in the free-operant psychophysical procedure: evidence for the involvement of D2 dopamine receptors.
    Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2007 Aug; 193(3):423-36. PubMed ID: 17484066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey.
    Katz JL; Witkin JM
    Psychopharmacology (Berl); 1993; 113(1):19-25. PubMed ID: 7862823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.
    Chen YC; Choi JK; Andersen SL; Rosen BR; Jenkins BG
    Psychopharmacology (Berl); 2005 Aug; 180(4):705-15. PubMed ID: 15536545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
    Sammut S; Bray KE; West AR
    Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani AH
    Pharmacol Biochem Behav; 2002 Dec; 74(1):187-97. PubMed ID: 12376167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.
    Platt DM; Rodefer JS; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2003 Mar; 166(3):298-305. PubMed ID: 12589523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice.
    Cook CD; Beardsley PM
    Pharmacol Biochem Behav; 2003 May; 75(2):363-71. PubMed ID: 12873628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding.
    Hodge CW; Chappelle AM; Samson HH
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1631-8. PubMed ID: 8986215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
    Sheppard B; Lehmann J; Cope ZA; Brown RW
    Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.